Raia Drogasil S.A. Sponsored ADR (RADLY)
OTC PINK OTC PINK Primary 
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8%
Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 8,015 shares, an increase of 138.8% from the February 12th total of 3,356 shares. Based on an average daily volume of 13,990 shares,
Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q3 2025 Earnings Call Transcript
Raia Drogasil S.A. (OTCPK:RADLY) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Renato Raduan - CEO & Member of Executive Board Flavio de Correia - Director of Investor Relations & Corporate Affairs Conference Call Participants Luiz Guanais - Banco BTG Pactual S.A.
Raia Drogasil: Valuation Burn Now, Healthy Gains Later
Raia Drogasil, Brazil's top pharmacy chain, has consistently delivered robust growth with an 18% CAGR in both revenue and profit over the last decade. Despite Brazil's macroeconomic challenges, the company remains financially strong, sustaining rapid store expansion with a Net Debt/EBITDA ratio consistently at 1.2x. The company plans to open 330-350 new stores in 2025, maintaining high ROIC and revenue growth driven by mature stores exceeding inflation.
